𝔖 Bobbio Scriptorium

✦ LIBER ✦

Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk

✍ Scribed by Sophie Gonbert; Sophie Malinsky; Andrei C. Sposito; Hervé Laouenan; Chantal Doucet; M.John Chapman; Joëlle Thillet

Book ID: 119435620
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 117 KB
Volume: 164
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(02)00072-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the effect of atorvastatin

Comparison of the effect of atorvastatin and simvastatin on levels of Lp(a) and Apo(a) fragments in hypercholesterolemic patients at high cardiovascular risk

✍ Gonbert, S.; Doucet, C.; Laouenan, H.; Chapman, J.; Thillet, J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Adiponectin plasma levels are increased

Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk

✍ Luis M. Blanco-Colio; Jose L. Martín-Ventura; Carmen Gómez-Guerrero; Xavier Masr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Th-P16:356 Atorvastatin diminished ICAM-

Th-P16:356 Atorvastatin diminished ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers (AIM) study

✍ Blanco-Colio, L.M.; Martin-Ventura, J.L.; De Teresa, E.; Farsang, C.; Gaw, A.; G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Elevated ICAM-1 and MCP-1 plasma levels

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration

✍ Luis Miguel Blanco-Colio; Jose Luis Martín-Ventura; Eduardo de Teresa; Csaba Far 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 127 KB

MSPI polymorphism at +83 bp in intron 1

MSPI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of high density lipoprotein cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease

✍ A. Pulkkinen; L. Viitanen; A. Kareinen; S. Lehto; M. Laakso 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Behalf of the ACTFAST investigators L.M.

Behalf of the ACTFAST investigators L.M. Blanco-Colio, J.L. Martín-Ventura, E. De Teresa, C. Saba Farsang, A. Gaw, G.F. Gensini, L.A. Leiter, A. Langer, P. Martineau, G. Hernández, J. Egido, ,Aumento de los valores plasmáticos de Fas soluble en pacientes con alto riesgo cardiovascular. Estudio de atorvastatina sobre los marcadores de inflamación (Atorvastatin on Inflammatory Markers, AIM) un subestudio de ACTFAST Increased soluble Fas Plasma Levels in subjects at High Cardiovascular Risk. Atorvastatin on Inflammatory Markers (AIM) Study, a Substudy of ACTFAST Arterioscler Thromb Vasc Biol 27 (2007) 168 174.

✍ José Martínez González 📂 Article 📅 2007 🏛 Elsevier Science 🌐 Spanish ⚖ 65 KB